Doping in sports and its spread to at-risk populations: An international review

World Psychiatry

Volumn 6, Issue 2, 2007, Pages 54-59

  Baron, David A ^a   Martin, David M ^a,b   Magd, Samir Abol ^a,c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Research and Development   (United States)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Adolescents; Doping; EPO; hGH; Performance enhancement; Sport; Steroids

Indexed keywords

ANABOLIC AGENT; ANASTROZOLE; ANDROSTENEDIOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOLDENONE; CANNABINOID; CLENBUTEROL; CLOMIFENE; COCAINE; DANAZOL; DIURETIC AGENT; EPHEDRINE; ERYTHROPOIETIN; FUROSEMIDE; GLUCOCORTICOID; GONADOTROPIN DERIVATIVE; HUMAN GROWTH HORMONE; INSULIN; LETROZOLE; MORPHINE; NARCOTIC AGENT; NEORECORMAN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYCODONE; PROBENECID; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GROWTH HORMONE; SALBUTAMOL; SOMATOMEDIN; TERBUTALINE; TEV TROPOIN; TIBOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ATHLETE; BONE GROWTH; CANCER; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; COLON POLYP; COMMUNITY; CREUTZFELDT JAKOB DISEASE; DOPING; DRUG COST; DRUG FORMULATION; DRUG SAFETY; EDUCATION PROGRAM; ENDOCRINE DISEASE; GLUCOSE INTOLERANCE; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY TUMOR; LIFESPAN; LIVER FUNCTION; LIVER TUMOR; MENTAL DISEASE; MODEL; POPULATION RISK; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; SIDE EFFECT; SPORT; SUBSTANCE ABUSE; TESTIS ATROPHY;

EID: 34347376493     PISSN: 17238617     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Bamberger M, Yaeger D. Over the edge. Sports Illustrated 1997; 14:62-70.
2. Wadler GI, Hainline B. Drugs and the athlete. Philadelphia: David, 1989.
3. Yesalis CE. History of doping in sport. In: Bahrke MS, Yesalis CE (eds). Performance enhancing substances in sport and exercise. Champaign: Human Kinetics, 2002:1-20.
4. Landry GL, Kokotaio PK. Drug screening in athletic settings. Curr Probl Pediatr 1994;24:344-59.
5. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic. Clin Chem 1997;43:1262-79.
6. World Anti-Doping Agency 2006 prohibited substances list. www.wada-ama.org.
7. Hsu AR, Barnholt KE, Grundmann NK et al. Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. Appl Physiol 2006;100:2031-40.
8. Healthy NJ. Performance enhancing drugs. www.healthynj.org.
9. Haupt HA, Rovere GD. Anabolic steroids, a review of the literature. Am J Sports Med 1984;12:469-84.
10. Buckley WE, Yesalis CE, Friedl KE et al. Estimated prevalence of anabolic steroids use by male adolescents. JAMA 1988;260:3441-5.
11. Irving LI, Wall M, Jeumark-Sztainer D. Steroid use of adolescents: findings from project EAT. J Adolesc Health 2002;30:243-52.
12. Kutcher EC, Lund BC, Pery PJ. Anabolic steroids: a review for the clinician. Sports Med 2002;32:285-96.
13. Sonksen PH. Insulin, growth hormone and sport. J Endocrinol 2001;170:13-25.
14. Ghaphery NA. Performance-enhancing drugs. Orthop Clin North Am 1995;26:433-42.
15. Pope HG, Katz DL, Champoux R. Anabolic-androgenic steroid use among 1,010 college men. Physician and Sports Medicine 1988;16:75-81.
16. DuRant RH, Escobedo LG, Heath GW. Anabolic-steroid use, strength training and multiple drug use among adolescents in the United States. Pediatrics 1995;96:23-8.
17. Lucas SE. Current perspectives on anabolic-androgenic steroid abuse. Trends Pharm Sci 1993;14:61-8.
18. DuRant RH, Rickert VI, Seymore C et al. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993;328:922-6.
19. Miller KE, Hoffman JH, Barnes GM et al. Adolescent anabolic steroid use, gender, physical activity and other problem behaviors. Substance Use and Misuse 2005;40:1637-57.
20. Clancy GP, Yates WR. Anabolic steroid use among substance abusers in treatment. J Clin Psychiatry 1992;53:97-100.
21. Bahrke MS, Yesalis CE, Kopstein AN et al. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med 2000;29:397-405.
22. Klatz RM, Goldman RM. Stopping the clock, dramatic breakthroughs in anti-aging and age reversal techniques. New York: Bantam Books, 1996.
23. Mayo Clinic On-Line. Teen athletes and performance enhancing substances: what parents can do. www.mayoclinic.com.
24. University of Oregon. Atlas and Athena Programs. www.ohsu.edu/hpsm/ index.
25. Committee on Sports Medicine and Fitness. Policy statement on the use of performance enhancing substances. Pediatrics 2005; 115:1103-7.